Aromatase Inhibitor-Associated Arthralgias

被引：20
|
作者：
Chlebowski, Rowan T. [1 ]
机构：
[1] Harbor UCLA Med Ctr, Dept Med, Los Angeles BioMed Res Inst, Torrance, CA 90509 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 30期
关键词：
PLUS VITAMIN-D; BREAST-CANCER; MUSCULOSKELETAL SYMPTOMS; POSTMENOPAUSAL WOMEN; JOINT SYMPTOMS; TENOSYNOVIAL CHANGES; ADJUVANT TREATMENT; BONE HEALTH; PAIN; TRIAL;
D O I：
10.1200/JCO.2009.23.3270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4032 / 4034
页数：4
相关论文
共 50 条
  • [21] Managing aromatase inhibitor-associated bone loss in breast cancer
    Lipton, Allan
    Gnant, Michael
    Aapro, Matti
    WOMENS HEALTH, 2007, 3 (04) : 441 - 448
  • [22] Therapeutic Options for the Management of Aromatase Inhibitor-Associated Bone Loss
    Gaudio, Agostino
    Xourafa, Anastasia
    Rapisarda, Rosario
    Castellino, Pietro
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (03) : 259 - 273
  • [23] MANAGING AROMATASE INHIBITOR-ASSOCIATED BONE LOSS: PRACTICAL GUIDANCE
    Hadji, P.
    Body, J.
    Aapro, M.
    Brufsky, A.
    Coleman, R.
    Guise, T.
    Lipton, A.
    Tubiana-Hulin, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 32 - 32
  • [24] Aromatase Inhibitor-Associated Musculoskeletal Symptoms: Etiology and Strategies for Management
    Henry, N. Lynn
    Giles, Jon T.
    Stearns, Vered
    ONCOLOGY-NEW YORK, 2008, 22 (12): : 1401 - 1408
  • [25] Practical guidance for the management of aromatase inhibitor-associated bone loss
    Hadji, P.
    Body, J. -J.
    Aapro, M. S.
    Brufsky, A.
    Coleman, R. E.
    Guise, T.
    Lipton, A.
    Tubiana-Hulin, M.
    ANNALS OF ONCOLOGY, 2008, 19 (08) : 1407 - 1416
  • [26] Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
    Hyder, Tara
    Marino, Christopher C.
    Ahmad, Sasha
    Nasrazadani, Azadeh
    Brufsky, Adam M.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [27] Validation of the modified score for the assessment and quantification of chronic rheumatoid affections of the hands (M-SACRAH) in aromatase inhibitor-associated arthralgias in breast cancer survivors
    Gupta, Smita R.
    Kolasinski, Sharon L.
    Stricker, Carrie
    DeMichele, Angela
    Mao, Jun J.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4258 - 4258
  • [28] Randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer: The hormones and physical exercise (HOPE) study
    Irwin, M. L.
    Cartmel, B.
    Gross, C.
    Ercolano, E.
    Fiellin, M.
    Capozza, S.
    Rothbard, M.
    Zhou, Y.
    Harrigan, M.
    Sanft, T.
    Schmitz, K.
    Neogi, T.
    Hershman, D.
    Ligibel, J.
    CANCER RESEARCH, 2013, 73
  • [29] Aromatase inhibitor-associated musculoskeletal pain: An overview of pathophysiology and treatment modalities
    Grigorian, Nelly
    Baumrucker, Steven J.
    SAGE OPEN MEDICINE, 2022, 10
  • [30] Association of Aromatase Inhibitor-Associated Musculoskeletal Symptoms with Ultrasonographic Changes at the Wrist
    Henry, N. L.
    Jacobson, J.
    Banerjee, M.
    Hayden, J.
    Smerage, J.
    Stearns, V
    Hayes, D. F.
    CANCER RESEARCH, 2009, 69 (24) : 527S - 527S
12345